Old Web
English
Sign In
Acemap
>
authorDetail
>
Georgy I. Kovalev
Georgy I. Kovalev
Pharmacology
Bicuculline
Chemistry
Receptor
Memantine
3
Papers
13
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
ERK1/2 kinases and dopamine D2 receptors participate in the anticonvulsant effects of a new derivative of benzoylpyridine oxime and valproic acid.
2021
European Journal of Pharmacology
Svetlana A. Litvinova
Tatyana A. Voronina
Evgeny A. Kondrakhin
Igor Olegovich Gaydukov
Artem I. Davletshin
Ekaterina V Vasileva
Georgy I. Kovalev
David G. Garbuz
Show All
Source
Cite
Save
Citations (0)
In silico Screening and Behavioral Validation of a Novel Peptide, LCGA-17, With Anxiolytic-Like Properties.
2021
Frontiers in Neuroscience
Anton V. Malyshev
Iuliia A. Sukhanova
Alexander Zlobin
Vasilina R. Gedzun
Vsevolod V. Pavshintsev
Ekaterina V Vasileva
Arthur O. Zalevsky
Igor I. Doronin
Nikita A. Mitkin
Andrey V. Golovin
Maxim L. Lovat
Georgy I. Kovalev
Yurii A. Zolotarev
Askar R. Kuchumov
Gennady A. Babkin
Bernhard Luscher
Show All
Source
Cite
Save
Citations (0)
Cerebrovascular and Neuroprotective Effects of Adamantane Derivative
2014
BioMed Research International
Ruben S. Mirzoyan
Tamara S. Gan’shina
Denis V. Maslennikov
Georgy I. Kovalev
Ivan A. Zimin
Boris M. Pyatin
Nina I. Avdyunina
Anna M. Kukhtarova
Nelly G. Khostikyan
Vahe S. Meliksetyan
Cristina B. Alikhanyan
Narine R. Mirzoyan
Show All
Source
Cite
Save
Citations (13)
1